Home > Insider Trading > Filing (0000899243-15-004431)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1512762	Coherus Biosciences Inc.	CHRS	Biological Products, (No Disgnostic Substances) (2836)	273615821

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622080	C. Alan Herman	Coherus Biosciences, Inc. 201 Redwood Shores Parkway, Suite 200 Redwood City CA 94065	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.0001 Par Value	Acquisiton	2015-09-01	11,333	$0.42	226,032	No	4	M	Direct
Common Stock, $0.0001 Par Value	Disposition	2015-09-01	6,024	$27.23	220,008	No	4	S	Direct
Common Stock, $0.0001 Par Value	Disposition	2015-09-01	5,309	$27.57	214,699	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option(right to buy)	Disposition	2015-09-01	11,333	$0.00	11,333	$0.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
80,027		2021-07-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	300,164	Indirect	By Trust

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
The transaction was executed in multiple trades in prices ranging from $26.42 to $27.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The transaction was executed in multiple trades in prices ranging from $27.43 to $27.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
The shares underlying this option are vested and exercisable as of the date hereof.